Vanda Pharmaceuticals
VNDA
#6947
Rank
โ‚ฌ0.47 B
Marketcap
8,07ย โ‚ฌ
Share price
0.00%
Change (1 day)
77.42%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -โ‚ฌ0.11 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.21 Billion. In 2024 the company made an earning of -โ‚ฌ35.31 Million a decrease over its 2023 earnings that were of -โ‚ฌ12.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.11 Billion203.38%
2024 -โ‚ฌ35.31 Million191.43%
2023 -โ‚ฌ12.12 Million-320.45%
2022 โ‚ฌ5.49 M-84.99%
2021 โ‚ฌ36.61 M54.8%
2020 โ‚ฌ23.65 M19.42%
2019 โ‚ฌ19.8 M4.93%
2018 โ‚ฌ18.87 M-228.6%
2017 -โ‚ฌ14.68 Million-8.98%
2016 -โ‚ฌ16.13 Million-53.79%
2015 -โ‚ฌ34.9 Million-30.18%
2014 -โ‚ฌ49.99 Million173.08%
2013 -โ‚ฌ18.31 Million-25.33%
2012 -โ‚ฌ24.52 Million163.61%
2011 -โ‚ฌ9.3 Million-221.15%
2010 โ‚ฌ7.67 M-124.53%
2009 -โ‚ฌ31.3 Million-29.44%
2008 -โ‚ฌ44.35 Million-36.2%
2007 -โ‚ฌ69.51 Million21.81%
2006 -โ‚ฌ57.07 Million170.55%
2005 -โ‚ฌ21.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.13 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ14.20 B-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ10.29 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ19.54 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ20.05 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.97 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚ฌ2.44 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA